For 45 years Fondation Merieux has been a leader in building clinical excellence and access to quality diagnostics with emphasis on country-level leadership in over a dozen countries including Mali, Haiti, Cambodia, Laos, China and Lebanon. "We strongly believe that a US footprint is a significant step forward in the mission to save lives and reduce the impact of infectious disease in some of the most vulnerable populations in the world."
Louise Gresham PhD, MPH, formerly Senior Director at the Nuclear Threat Initiative in Washington DC, has been named CEO. Dr. Gresham has expertise in national and international disease surveillance systems in the Middle East, Southern Africa, and SE Asia, in particular managing the intersection of public health, international policy and global security. Dr. Gresham participated in the development of the first modern tuberculosis laboratory in the Democratic People’s Republic of Korea. "We are leveraging years of experience in strengthening local health systems and local leadership and are forming new and trusted linkages with US partners to achieve our mission-based results around the world." Fondation Merieux USA benefits from an international Board with Pr. David Heymann, Health Protection Agency (UK) as Chair, and taking prominent posts are:
Stéphane Bancel, Modema (USA)
Didier Cherpitel, Fondation Mérieux (France)
Kevin De Cock, CDC (USA)
Warren Johnson, Cornell University (USA)
Philippe Lacoste, Fondation Mérieux (France)
Karine Mehler, Fondation Mérieux (France)
Benoit Miribel, Fondation Mérieux (France)
Stanley Plotkin, Vaxconsult (USA)
Fondation Mérieux USA, Inc. is a charitable not-for-profit organization located in the Washington, DC Metro area. For additional information and interest in partnering with Fondation Merieux USA please visit www.fondation-merieux.org.
Director of Fondation Mérieux USA, Inc.
Tel: +1 202 281 8945
E-mail: Send an e-mail